# Reshape Biotech **Source:** https://geo.sig.ai/brands/reshape-biotech **Vertical:** Healthcare **Subcategory:** General **Tier:** Challenger **Website:** reshapebiotech.com **Last Updated:** 2026-04-14 ## Summary Copenhagen YC W21 lab automation robots for biotech at $28.2M total ($20M Astanor Series A Apr 2024) and $8.3M revenue 2024; 500K+ hours saved annually serving alternative protein and sustainable ag competing with Opentrons for microbiology automation. ## Company Overview Reshape Biotech is a Copenhagen, Denmark-based laboratory automation robotics company — backed by Y Combinator (W21) with $28.2 million in total funding including a $20 million Series A led by Astanor Ventures in April 2024 with participation from YC — providing biotechnology companies, life sciences research organizations, and food technology companies with specialized single-function robots that automate repetitive microbiological laboratory workflows, generating $8.3 million in annual revenue in 2024 with a 55-person team. Reshape's robots have saved customers over 500,000 hours of manual lab work annually, serving the sustainable food technology and alternative protein sector (fermentation-based food production, precision fermentation, cultivated meat) alongside traditional biotech research laboratories that use microbiology workflows at scale. Reshape Biotech's robot design philosophy ('one robot, one task') addresses the ergonomics and accuracy failure modes of manual microbiological workflows: the tedious, repetitive nature of tasks like inoculating hundreds of culture plates, filling growth media into multi-well plates, or analyzing colonies under microscopes creates both human error (accuracy degrading with fatigue on repetitive tasks) and ergonomic injury risk for laboratory workers performing thousands of pipetting motions per shift. Reshape builds dedicated robots optimized specifically for each workflow — the Reshape Plate Filler (automated liquid handling into culture plates), the Reshape Streaker (automated bacterial streaking for colony isolation), and the Reshape Colony Counter (AI-powered image analysis for colony counting and classification) — rather than attempting general-purpose lab automation that trades depth for breadth. The mechatronics engineering (compact robotic hardware designed for standard lab bench footprints) and machine learning image analysis (interpreting microscopy and plate imaging data with expert-level accuracy) combine to create the accuracy and throughput improvements that justify capital investment. In 2025, Reshape Biotech competes in the laboratory automation, life sciences robotics, and biotech lab equipment market with Hamilton Robotics (Hamilton Company, liquid handling robots), Azenta Life Sciences (NASDAQ: AZTA, integrated biobanking and lab automation), and Opentrons (accessible lab automation robots, $200M raised) for biotech laboratory team workflow automation adoption. The sustainable food technology market (alternative proteins, precision fermentation) has grown rapidly as food companies invest in fermentation-based manufacturing that uses the same microbiology workflows (plating, counting, inoculating) as pharmaceutical biotech — creating a new customer segment for lab automation beyond traditional drug discovery. Astanor Ventures' food system investment focus (Astanor is a leading food and agriculture technology VC) reflects the sustainable food tech application of Reshape's platform. Y Combinator W21 backing connected Reshape with the life sciences and climate tech investor community. The 2025 strategy focuses on growing the alternative protein and precision fermentation customer base, building the automated microbiology workflows for industrial fermentation process development, and expanding the robot-as-a-service subscription model for laboratory teams without capital equipment procurement budgets. ## Frequently Asked Questions ### What is Reshape Biotech? Reshape Biotech is a lab automation company founded in 2019 that builds specialized robots to automate everyday tasks of microbiologists. The company uses mechatronics, cloud computing, and machine-learning-based data analysis to help biotech companies save over 500,000 hours annually on manual processes. ### What products and services does Reshape Biotech offer? Reshape Biotech offers lab automation solutions including specialized microbiology robots for tasks like plate filling and image analysis. Their products utilize cloud computing and machine learning, with one robot designed per specific function for ease of use. ### Who are Reshape Biotech's target customers? Reshape Biotech serves life sciences and biotechnology research laboratories seeking to eliminate repetitive manual work. Their customers include biotech companies working on alternative protein development and sustainable agriculture. ### When was Reshape Biotech founded? Reshape Biotech was founded in 2019. The company participated in Y Combinator's Winter 2021 (W21) cohort. ### Where is Reshape Biotech located? Reshape Biotech is based in Ireland. ### How much funding has Reshape Biotech raised? Reshape Biotech has raised $28.2M in total funding. This includes a $20M Series A round in April 2024 led by Astanor Ventures with participation from Y Combinator. ### What are Reshape Biotech's key achievements and metrics? Reshape Biotech achieved $8.3M in revenue in 2024 with a team of 55 employees. The company's automation solutions save biotech companies over 500,000 hours annually on manual processes. ### What is Reshape Biotech's technology approach? Reshape Biotech combines mechatronics, cloud computing, and machine-learning-based data analysis in their automation solutions. They use a one-robot-per-function approach rather than multi-purpose robots for ease of use. ### How does Reshape Biotech's approach differ from other lab automation companies? Reshape Biotech provides one robot per function rather than multi-purpose robots, making their solutions easier to use. This specialized approach focuses on automating specific everyday tasks of microbiologists like filling plates and analyzing images. ### What is Reshape Biotech's latest news? In April 2024, Reshape Biotech closed a $20M Series A funding round led by Astanor Ventures with Y Combinator participation. The company achieved $8.3M in revenue in 2024 and has grown to 55 employees while saving customers over 500,000 hours annually. ## Tags healthtech, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*